Brief: Sun Pharma Says USFDA Approved The Supplemental Biologics License Application For Ilumya
BRIEF-Sun Pharma Says USFDA Approved The Supplemental Biologics License Application For Ilumya Oct 30 (Reuters) - Sun Pharmaceutical Industries Limited SUN.NS:
SUN PHARMA - USFDA APPROVED THE SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR ILUMYA
Source text: ID:nBSE2Y8Gmk
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses